Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. (Q35119075)
Jump to navigation
Jump to search
scholarly article
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. |
scholarly article |
Statements
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice (English)
Sarah Swerdlow
Theodore M Duffy
Roberto Weinmann
Francis Y Lee
31 October 2006
1 reference
1 reference